- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/519 - PyrimidinesHydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
Patent holdings for IPC class A61K 31/519
Total number of patents in this class: 20163
10-year publication summary
|
1119
|
1187
|
1186
|
1312
|
1324
|
1428
|
1528
|
1447
|
1570
|
1607
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Novartis AG | 10612 |
297 |
| Incyte Corporation | 1039 |
292 |
| Boehringer Ingelheim International GmbH | 4636 |
246 |
| Janssen Pharmaceutica N.V. | 3358 |
176 |
| F. Hoffmann-La Roche AG | 7937 |
169 |
| Merck Sharp & Dohme LLC | 3732 |
167 |
| Pfizer Inc. | 3401 |
166 |
| Taisho Pharmaceutical Co., Ltd. | 869 |
166 |
| AstraZeneca AB | 2857 |
165 |
| Pharmacyclics LLC | 243 |
162 |
| The Regents of the University of California | 20303 |
157 |
| Gilead Sciences, Inc. | 2106 |
153 |
| Genentech, Inc. | 4016 |
151 |
| Dana-Farber Cancer Institute, Inc. | 2626 |
146 |
| Bristol-myers Squibb Company | 4826 |
136 |
| Amgen Inc. | 4256 |
135 |
| Incyte Holdings Corporation | 663 |
132 |
| Hoffmann-La Roche Inc. | 3546 |
130 |
| Merck Patent GmbH | 5752 |
130 |
| Takeda Pharmaceutical Company Limited | 2721 |
130 |
| Other owners | 16757 |